Repositorio Dspace

Need for resuscitation in preterm neonates less than 32 weeks treated with antenatal magnesium sulphate for neuroprotection.

Mostrar el registro sencillo del ítem

dc.contributor.author Lloreda-García, José-María
dc.contributor.author Lorente-Nicolas, Ana
dc.contributor.author Bermejo-Costa, Francisca
dc.contributor.author Martínez-Uriarte, Juan
dc.contributor.author López-Pérez, Rocío
dc.date.accessioned 2026-10-21T06:14:21Z
dc.date.available 2026-10-21T06:14:21Z
dc.date.issued 2016-07
dc.identifier.citation Lloreda-Garcia JM, Lorente-Nicolás A, Bermejo-Costa F, Martínez-Uriarte J, López-Pérez R. Necesidad de reanimación en prematuros menores de 32 semanas expuestos a sulfato de magnesio para neuroprotección fetal. Revista Chilena de Pediatría. julio de 2016;87(4):261-7. doi:10.1016/j.rchipe.2015.11.006
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/28821
dc.description.abstract INTRODUCTION: Magnesium sulphate administration is recommended for foetal neuroprotection in pregnant women at imminent risk of early preterm birth. OBJECTIVE: To evaluate the relationship between intrapartum magnesium sulphate for foetal neuroprotection and delivery room resuscitation of preterm infants less 32 weeks. PATIENTS AND METHOD: A prospective observational study was conducted on preterm infants less 32 weeks exposed to magnesium sulphate for neuroprotection, and a comparison made with another historic group immediately before starting this treatment. Cases in both groups that had not reached lung maturity with corticosteroids were rejected. The rates of resuscitation, morbidity and mortality for each of the groups were analysed and compared. RESULTS: There was a total of 107 preterm, with 56 exposed to magnesium sulphate. Rate of advanced resuscitation were similar between the two groups. There were no other differences in mortality, invasive mechanical ventilation, time to first stool, and other comorbidities. CONCLUSIONS: Intrapartum magnesium sulphate for foetal neuroprotection was not associated with an increased need for intensive delivery room resuscitation and other morbidities in these cohorts of less than 32 weeks preterm infants.
dc.language.iso spa
dc.rights Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internaciona
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es *
dc.subject.mesh Adult
dc.subject.mesh Female
dc.subject.mesh Humans
dc.subject.mesh Infant, Newborn
dc.subject.mesh Infant, Premature
dc.subject.mesh Magnesium Sulfate/administration & dosage/adverse effects
dc.subject.mesh Male
dc.subject.mesh Neuroprotective Agents/administration & dosage/adverse effects
dc.subject.mesh Pregnancy
dc.subject.mesh Prenatal Care/methods
dc.subject.mesh Prospective Studies
dc.subject.mesh Resuscitation/statistics & numerical data
dc.subject.mesh Young Adult
dc.title Need for resuscitation in preterm neonates less than 32 weeks treated with antenatal magnesium sulphate for neuroprotection.
dc.type info:eu-repo/semantics/article 
dc.identifier.pmid 26778008
dc.relation.publisherversion http://linkinghub.elsevier.com/retrieve/pii/S037041061500296X
dc.identifier.doi 10.1016/j.rchipe.2015.11.006
dc.journal.title Revista Chilena de Pediatría
dc.identifier.essn 0717-6228


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internaciona Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internaciona

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta